Renaissance Technologies - SILVERBACK THERAPEUTICS INC ownership

Quarter-by-quarter ownership
Renaissance Technologies ownership history of SILVERBACK THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$521
-74.4%
137,700
-54.7%
0.00%
-66.7%
Q2 2023$2,039
-5.3%
304,300
-8.0%
0.00%0.0%
Q1 2023$2,152
-18.9%
330,600
+6.3%
0.00%
-25.0%
Q4 2022$2,653
-99.8%
311,000
-1.1%
0.00%
+100.0%
Q3 2022$1,660,000
-28.7%
314,400
-42.8%
0.00%
-33.3%
Q2 2022$2,329,000
-1.1%
549,299
-18.1%
0.00%0.0%
Q1 2022$2,354,000
-4.0%
670,542
+82.2%
0.00%0.0%
Q4 2021$2,451,000
+110.6%
368,000
+215.6%
0.00%
+50.0%
Q3 2021$1,164,000116,6000.00%
Other shareholders
SILVERBACK THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Orbimed Advisors 8,740,887$87,234,0000.96%
Boxer Capital, LLC 1,675,377$16,720,0000.58%
EcoR1 Capital, LLC 1,184,710$11,823,0000.41%
Nantahala Capital Management 1,226,631$12,242,0000.39%
5AM Venture Management, LLC 169,748$1,694,0000.34%
COMMODORE CAPITAL LP 97,143$969,0000.26%
RA Capital Management 1,742,186$17,387,0000.24%
HighVista Strategies LLC 22,434$224,0000.15%
Rhenman & Partners Asset Management AB 150,000$1,497,0000.10%
Woodline Partners LP 425,261$4,244,0000.07%
View complete list of SILVERBACK THERAPEUTICS INC shareholders